PneumaCare, founded by Cambridge entrepreneurs and medical professionals in 2009, is pioneering the design and development of life-saving technologies in non-contact medical monitoring instruments. Using novel 3D-imaging technology developed by the University of Cambridge, the PneumaCare team created the PneumaScan™, a revolutionary medical device for non-invasive respiratory monitoring. Highly portable and simple to operate, the PneumaScan™ could be used in clinical practice, critical care and the home. PneumaScan™ is low cost, non-contact platform for lung function assessment, which is based on light scanning, motion-capture technology and image processing. Using PneumaScan™, patients could be assessed while breathing naturally or performing spirometric manoeuvres without the need to interact with or be in contact with the device. The PneumaScan™ could be used with patients who could not be monitored with conventional equipment, such as spirometers. PneumaScan™ uses light to measure and monitor how deeply and how quickly a patient is breathing, and what muscle groups are being used. The PneumaScan™ family of products is a set of non-invasive 3D-imaging systems that enable clinicians to access many different patient-types. The PneumaScan™’s dynamic 3D-imaging approach provides novel information and a fresh clinical perspective about the intra-thoracic motion during a breath, which has implications for both diagnostics and critical care monitoring.
PneumaScan™ is developed in collaboration with members of the University of Cambridge, tested in clinical trials at Addenbrooke’s Hospital, Cambridge, and with an extended presence in Great Ormond Street Hospital, London, and its effectiveness is supported by presentations, publications and evidence. PneumaCare’s constant contact with the end user and access to creative organisations including the University of Cambridge and Plextek, enabled us to extend the original idea into a platform technology that is finding new applications such as intensive care, home monitoring and physiotherapy. PneumaCare is working on innovative technologies to improve the quality of diagnosis and outcomes for those suffering from lung disease, and in particular the considerable numbers of patients who are unable to benefit from the current techniques for monitoring lung function. The University of Cambridge Engineering Department is collaborating with PneumaCare in the development of novel data capture systems, modelling and analysis approaches. Plextek Limited, a well-established engineering consultancy specializing in electronics, imaging and product design, provides the expertise and engineering processes required to develop the technology into a commercial system ready for large-scale manufacture. Addenbrooke’s Hospital, Cambridge, hosted clinical evaluations of the PneumaScan™. Great Ormond Street Hospital (GOSH), London incorporated PneumaScan™ into its programme of novel technology evaluation.